Search for: "Novartis Pharmaceuticals Corporation" Results 121 - 140 of 150
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Oct 2012, 12:15 pm by Michelle Yeary
Novartis Pharmaceuticals Corporation a couple of weeks ago.  [read post]
1 Oct 2010, 5:35 am by David G. Badertscher
Attorney Zane Memeger said Novartis Pharmaceuticals has agreed to pay a criminal fine and forfeiture of $185 million, and also agreed to pay $237.5 million to resolve civil liabilities for its off-label marketing of six drugs.U.K. [read post]
28 Jun 2016, 3:39 pm by FDABlog HPM
  There’s also the short-lived lawsuit Novartis Pharmaceuticals Corporation filed back in 2010 after FDA mistakenly approved ANDA 078278 for a generic version of FAMVIR (famciclovir) Tablets (see our previous post here). [read post]
30 Jan 2020, 10:49 am by luiza
  Correctional facilities operators Management and Training Corporation, Cornell Companies, Inc. [read post]
23 Mar 2007, 11:35 am
., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel Corporation, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Monsanto, Motorola, Novartis, Patent Café.com Inc., Pfizer, Procter… [read post]
3 Mar 2020, 4:00 am by Alan Macek
In Novartis Pharmaceuticals Canada Inc. v. [read post]
27 Dec 2007, 7:09 am
Novartis Pharmaceuticals Corp., 2007 WL 1521138 (D.N.J. [read post]
5 Jan 2011, 9:22 am by Gerald L. Maatman, Jr.
Novartis Pharmaceuticals Corp., Case No. 04-CV-9194 (S.D.N.Y.) following a seven-week trial in the Spring of 2010.  [read post]
19 Oct 2009, 1:24 am
The ruling wipes out verdicts of $33 million against Novartis, $81 million against GlaxoSmithKline, and $215 million (reduced post-trial to $160 million) against AstraZeneca. [read post]
2 Mar 2015, 2:43 pm
ZTE Corporation is ramping up to take advantage of the new legal environment that has resulted from the settlement between Qualcomm and the Chinese National Development and Reform Commission (NDRC) over claims that the company’s licensing practices had violated the country’s Anti-Monopoly Law, recounts Neil.* Groundless threats to sue for IP infringement: the end of an era? [read post]
26 Jul 2017, 7:24 pm by FDABlog HPM
It was just earlier this month that FDA’s Oncologic Drugs Advisory Committee recommended that FDA approve the first gene therapy product: Novartis Pharmaceuticals Corporation’s BLA 125646 for Tisagenlecleucel for the treatment of pediatric and young adult patients 3 to 25 years of age with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia. [read post]
13 Jul 2016, 8:52 pm by FDABlog HPM
We recently got our hands on a Memorandum prepared by FDA’s Office of Generic Drugs concerning the Agency’s December 3, 2015 approval of Sun Pharma Global FZE’s (“Sun’s”) ANDA 078340 for generic versions of Novartis Pharmaceuticals Corporation’s GLEEVEC (imatinib mesylate) Tablets, 100 mg and 400 mg, that we though was worth sharing with folks. [read post]
7 Jun 2007, 1:17 am
The lawsuit says Christopher Woods sought treatment for the condition, called severe priapism, the day after he bought the nutrition beverage made by the pharmaceutical company Novartis AG at a drugstore and drank it. [read post]